Innate immunity is the body’s rapid, first line of defense against infection, relying on cells and molecules that recognize common features of microbes rather than specific pathogens. It is evolutionarily ancient and conserved across many organisms, from invertebrates to humans.

A central concept is pattern recognition. Innate immune cells express pattern recognition receptors that detect pathogen associated molecular patterns such as bacterial cell wall components, viral RNA, or fungal carbohydrates. These receptors trigger signaling cascades leading to inflammation, production of cytokines, and activation of antimicrobial mechanisms. The same system can also sense danger associated molecular patterns released from damaged or dying cells, linking infection, tissue injury, and sterile inflammation.

Cells of the innate immune system include macrophages, neutrophils, dendritic cells, natural killer cells, and innate lymphoid cells. They engulf and kill microbes, secrete inflammatory mediators, and shape the emerging adaptive response. Physical and chemical barriers such as skin, mucous membranes, antimicrobial peptides, and the complement system form part of this network.

Innate immunity is not simply a rigid, unchanging shield. Research shows functional adaptation and a phenomenon called trained immunity, in which prior exposure to certain stimuli leaves a lasting imprint on innate cells and their progenitors, enhancing or altering later responses. Dysregulation of innate pathways contributes to chronic inflammatory diseases, autoimmunity, allergy, metabolic disorders, and cancer. Understanding how innate sensors, signaling pathways, and effector mechanisms operate and interact with the microbiota and environment is guiding development of vaccines, adjuvants, anti inflammatory therapies, and immunotherapies that harness or modulate this fundamental defense system.